Objective: To evaluate the impact of preoperative leukocytosis among patients with endometrial carcinoma.

Objective: To evaluate the impact of preoperative leukocytosis among patients with nonendometrioid endometrial carcinoma.

Conclusions: Among patients with nonendometrioid endometrial carcinoma, preoperative leukocytosis is independently associated with an increased risk of recurrence and death.

Conclusions: Preoperative leukocytosis, among endometrial cancer patients, was independently associated with increasing tumor size and independently imposed an increased risk of death.